SU-DHL-2

Export PDF

Strain Information

Cell Line

SU-DHL-2

Cat. NO.

NM-B14

Model Description

Human diffuse tissue lymphoma cell line

Strain State

Validation of tumorigenic capacity

Validation Data

*Wild-type cell lines are not for sale, and only applied to construction of tumor bearing mice and in-vivo efficacy studies.

Related Strain(s)

MC38-hPD-L1/hCLAUDIN 18.2
Cell Line：

MC38-hPD-L1/hCLAUDIN 18.2

Cat. NO.：NMC-230113
CT26-hPD-L1/hCLAUDIN 18.2
Cell Line：

CT26-hPD-L1/hCLAUDIN 18.2

Cat. NO.：NMC-230112
H22-Luc-hGPC3
Cell Line：

H22-Luc-hGPC3

Cat. NO.：NM-GA01-TM05
CT26-hDLL3
Cell Line：

CT26-hDLL3

Cat. NO.：NMC-230087
NCI-H929-Luc
Cell Line：

NCI-H929-Tg(luc)/Smoc

Cat. NO.：NM-GS03-1

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more